Role of HIV glycan shield in mucus penetration
Role of HIV glycan shield in mucus penetration
批准号:
10403303
负责人:
Preethi Lourdes Chandran
金额:
$7.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-11-01 至 2023-10-31
关键词:
AdhesionsAffectAfrica South of the SaharaAfricanAfrican American populationAgeAtomic Force MicroscopyBacterial VaginosisBindingBiologicalCellsChronic DiseaseClinicalCrowdingDataDepositionDevelopmentDiffuseDiseaseEpithelialEstrogensEthnic OriginExcisionGoalsHIVHIV InfectionsHIV SeronegativityHIV riskHIV-1ImageInfectionInvestigationIrrigationLeadLinkMediatingMenstrual cycleMethodsMicroscopyMinority GroupsMissionMucinsMucous MembraneMucous body substanceNatureParticipantParticle SizePatientsPatternPenetrationPilot ProjectsPlayPolysaccharidesPredispositionPremenopauseProteinsRaceReportingRoleRouteSamplingSiteSourceSurfaceTechnologyTestingTissuesUnited States National Institutes of HealthVaginaVariantVesicular stomatitis Indiana virusVirusWomanWomen&aposs Interagency HIV Studybiobankbiophysical analysiscervicovaginalcomorbiditydisparity reductionembryo tissueexhaustionhigh rewardhigh riskinternal controllight scatteringnew therapeutic targetnovelpatient populationpreventreproductivescreeningsugartransmission processvaginal transmissionviral transmission
中文摘要
项目总结
英文摘要
Project Summary
HIV-1 infection is a devastating disorder which disproportionally affects Africans in Sub-Saharan Africa and African-
Americans in US. Vaginal transmission remains the most common route of HIV infection among women who represent
over half of HIV infections globally. In this route, the first barrier to virus penetration is the mucus layer. The mucus is a
crowded network of heavily-glycosylated proteins called mucins. While the vaginal mucus is generally effective in
containing HIV penetration, it is not consistent and fundamental questions about when and why it fails to trap virus
remain unanswered. Like mucin molecules, the HIV virus is also heavily glycosylated. When HIV-1 enters mucus, the
sugars between the virus and mucus will be the first to make contact. This study proposes a novel hypothesis that the
adhesions that form between the virus and mucin sugars play a role in determining if mucin traps virus. The premise for
the hypothesis comes from biophysical studies which found that each of the sugars on virus and mucin adhere only to
specific sugar partners. The hypothesis will be tested with mucins from stored cervicovaginal lavage samples (CVL)
obtained from participants in the Women's Interagency HIV Study (WIHS). The samples are exhaustively catalogued
against relevant participant details (e.g., age, ethnicity, menstrual cycle, etc.). The study will select paired samples
collected prior and during an episode of Bacterial Vaginosis (BV) from a subset of participants who are premenopausal
and also HIV negative. The mucus sugar composition is known to shift in BV infection, and BV also creates a biologic
state that is associated with increased susceptibility to HIV acquisition. We will determine how virus adhesion to mucins
varies in CVL between matched BV+ and BV- states to test the hypothesis that sugar composition and sugar-sugar
adhesions change and play a role in virus entrapment by mucus. The study is significant because while sugars on virus
are relatively conserved, those on mucins vary with age, race, comorbidities, and reproductive cycle. If the hypothesis is
true, the virus entrapment by sugar-sugar adhesion and therefore its penetration into mucus is expected to change with
mucus sugar composition. This implies that patient mucus sugar composition can be screened for vulnerability to HIV
infection. Moreover, systematic changes in the vulnerability (with age, race, reproductive cycle, co-morbidities, etc.) can
be assessed with the ultimate goal of identifying possible methods to alter women's susceptibility to HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of HIV glycan shield in mucus penetration
-
批准号:10516749
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2021
-
负责人:Preethi Lourdes Chandran
-
依托单位:
海外基金